iPhone app iPad app Android phone app Android tablet app

Biologic Drugs

Taking Care of Business (Interests), It's a Bipartisan Cause

James Love | Posted 11.06.2012 | Politics
Read More: Biosimilars, Pharmaceutical Industry, Data Exclusivity, Tpp, Monopoly Rights, Intellectual Property, Biologic Drugs, Trans-Pacific Partnership, Politics News
James Love

2012-08-28-scblog2.pngWhile the GOP and Democratic conventions highlight the differences between the parties, there are some bipartisan issues -- and one of the biggest is taking care of corporate interests.

Read Whole Story

Biologic Drugs May Be Cheaper, But Are They Safe?

John Horton | Posted 05.25.2011 | Home
Read More: Biologic New Medicine, What Are Biologics, Biologic Drugs, Biologics, Biologics Definition, Home News
John Horton

Biologics are an exciting new world of medicine. But the EMA's new guidelines should put patient safety first by requiring biosimilars to be held to the same safety and standards as the original drug.

Read Whole Story

Are Unsafes Drugs An 'Acceptable Risk?' FDA Should Say 'No!'

John Horton | Posted 05.25.2011 | Home
Read More: Biosimilars, FDA Biologics, FDA Biosimilars, FDA Biologic Drugs, Biosimilar Drugs, Biologic Drugs, Biologics, Home News
John Horton

As a matter of common sense, the FDA's process for biosimilars shouldn't sacrifice patient safety.

Read Whole Story

House Health Care Bill: A Death Sentence For My Fellow Breast Cancer Survivors

Jane Hamsher | Posted 05.25.2011 | Politics
Read More: Health Care Bill, Anna Eshoo, Medical Students, Breast Cancer, Kay Hagan, Biologics, Nancy Pelosi, Avastin, Herceptin, Fda, Biologic Drugs, Health Care Reform, Politics News
Jane Hamsher

Pelosi made a choice about the lifesaving biologic drugs I took when I was in chemotherapy that will cost many fellow breast cancer survivors everything they own, and quite possibly their lives.

Read Whole Story